Testosterone levels in men with chronic migraine

被引:24
|
作者
Shields, Lisa B. E. [1 ]
Seifert, Tad [1 ]
Shelton, Brent J. [2 ]
Plato, Brian M. [1 ]
机构
[1] Norton Healthcare, Norton Neurosci Inst, Louisville, KY USA
[2] Univ Kentucky, Sch Med, Markey Canc Ctr, Lexington, KY 40536 USA
来源
NEUROLOGY INTERNATIONAL | 2019年 / 11卷 / 02期
关键词
Neurology; Migraine; Testosterone; Hypothalamus; Hypogonadism; SYMPTOMS; HEADACHE; HORMONES; THERAPY; URINARY;
D O I
10.4081/ni.2019.8079
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic migraine is a frequent and debilitating condition affecting 14% of the general population. This prospective observational pilot study investigated whether men with chronic migraine have lower than expected total serum testosterone levels. We identified 14 men ages 26-51 at our Institution who fulfilled the ICHD-3b criteria for chronic migraine and obtained serum total testosterone levels. The mean total testosterone level in our 14 patients was 322 ng/dL (range: 120-542 ng/dL) which is in the lower 5% of the reference range for our laboratory (300-1080 ng/dL). Men with chronic migraine had lower total testosterone levels compared to published age-matched normative median values by a median difference of 62 ng/dL (P=0.0494). This finding suggests that hypothalamic regulation is altered in patients with chronic migraine. Further studies are warranted to determine whether testosterone supplementation in men with chronic migraine reduces the number of headaches or the associated symptoms of hypogonadism.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [41] Is PSA influenced by testosterone levels in aging men?
    Marks, Leonard S.
    Roehrborn, Claus G.
    Marberger, Michael
    Wilson, Timothy H.
    Rittmaster, Roger S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 301 - 301
  • [42] Impact of testosterone levels and testosterone replacement therapy on men's health
    Karbowska, Zuzanna
    Cierpiszewska, Katarzyna
    Maruszczak, Klara
    Sukhachova, Ivanna
    Szwankowska, Dominika
    Piotrowski, Igor
    JOURNAL OF MEDICAL SCIENCE, 2024, 93 (01): : 57 - 68
  • [43] Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels
    Cherrier, M. M.
    Anderson, K.
    Shofer, J.
    Millard, S.
    Matsumoto, A. M.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2015, 30 (04): : 421 - 430
  • [44] ACUTE SUPPRESSION OF ENDOGENOUS TESTOSTERONE LEVELS BY EXOGENOUS TESTOSTERONE IN NORMAL MEN
    FUJIOKA, M
    SHINOHARA, Y
    BABA, S
    IRIE, M
    INOUE, K
    LIFE SCIENCES, 1987, 41 (08) : 945 - 949
  • [45] Serum testosterone levels and score of chronic mountain sickness in Peruvian men natives at 4340 m
    Gonzales, G. F.
    Tapia, V.
    Gasco, M.
    Gonzales-Castaneda, C.
    ANDROLOGIA, 2011, 43 (03) : 189 - 195
  • [46] Testosterone treatment for men with chronic heart failure
    Pugh, PJ
    Jones, RD
    West, JN
    Jones, TH
    Channer, KS
    HEART, 2004, 90 (04) : 446 - 447
  • [47] Testosterone concentrations in men on chronic glucocorticosteroid therapy
    Fitzgerald, RC
    Skingle, SJ
    Crisp, AJ
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1997, 31 (02): : 168 - 170
  • [48] Procalcitonin levels in chronic migraine patients
    Dominguez Vivero, Clara
    Leira Feijoo, Yago
    Pineiro, Marta Saavedra
    Campos Perez, Francisco
    Sobrino, Tomas
    Castillo, Jose
    Leira, Rogelio
    CEPHALALGIA, 2019, 39 : 78 - 78
  • [49] Procalcitonin levels in chronic migraine patients
    Dominguez, C.
    Leira, Y.
    Saavedra-Pineiro, M.
    Rodriguez-Osorio, X.
    Perez-Mato, M.
    Sobrino-Moreiras, T.
    Campos-Perez, F.
    Castillo Sanchez, J. A.
    Leira Muino, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 158 - 158
  • [50] CSF glutamate levels in chronic migraine
    Peres, MFP
    Zukerman, E
    Soares, C
    Augusto, S
    Alonso, EO
    Santos, BFC
    Faulhaber, MHW
    CEPHALALGIA, 2004, 24 (02) : 151 - 152